Market positioning Pegasi focuses on accelerating cancer diagnosis and treatment in Latin America, presenting a clear regional value proposition for healthcare providers and hospitals seeking faster patient turnarounds and improved outcomes.

Digital health stack Utilizes a modern tech stack and data-driven approach, leveraging analytics to shorten the suspicion-to-treatment timeline, which can be packaged to health networks as a capability to optimize patient flow and clinical decision support.

Growth potential With 11-50 employees and mid six-figure to lower seven-figure revenue while pursuing expansion, Pegasi is likely open to partnerships with regional hospital groups, diagnostic centers, and payers seeking scalable cancer care acceleration solutions.

Financial levers Current funding and revenue indicators suggest opportunities for co-investment, joint ventures, or pilot programs to demonstrate ROI in reducing time-to-treatment and improving patient outcomes across Latin American markets.

Competitive fit Align Pegasi with adjacent digital health and medical device players, such as imaging, telemedicine, and data infrastructure vendors, to offer integrated workflows that strengthen hospital throughput and patient experience.